首页> 外文OA文献 >Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and mass spectrometry (CSIP-MS).
【2h】

Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and mass spectrometry (CSIP-MS).

机译:通过细胞表面免疫沉淀和质谱(CSIP-MS)鉴定脑膜炎球菌的免疫蛋白质组。

摘要

Most healthy adults are protected from meningococcal disease by the presence of naturally acquired anti-meningococcal antibodies; however, the identity of the target antigens of this protective immunity remains unclear, particularly for protection against serogroup B disease. To identify the protein targets of natural protective immunity we developed an immunoprecipitation and proteomics approach to define the immunoproteome of the meningococcus. Sera from 10 healthy individuals showing serum bactericidal activity against both a meningococcal C strain (L91543) and the B strain MC58, together with commercially available pooled human sera were used as probe anti-sera. Immunoprecipitation was performed with each serum sample and live cells from both meningococcal strains. Immunoprecipitated proteins were identified by mass spectrometry. Analysis of the immunoproteome from each serum demonstrated both pan-reactive antigens that were recognised by most sera as well as subject-specific antigens. Most antigens were found in both meningococcal strains but a few were strain-specific. Many of the immunoprecipitated proteins have previously been characterised as surface antigens including adhesins and proteases, several of which have been recognised as vaccine candidate antigens e.g. fHBP, NadA and NHBA. The data clearly demonstrates the presence of meningococcal antibodies in healthy individuals with no history of meningococcal infection and a wide diversity of immune responses. The identification of the immuno-reactive proteins of the meningococcus provides a basis for understanding the role of each antigen in the natural immunity associated with carriage and may help to design vaccination strategies.
机译:大多数健康的成年人由于存在自然获得的抗脑膜炎球菌抗体而免受脑膜炎球菌病的侵害。然而,这种保护性免疫的靶抗原的身份仍然不清楚,特别是对于针对血清群B疾病的保护。为了鉴定天然保护性免疫的蛋白质靶标,我们开发了一种免疫沉淀和蛋白质组学方法来定义脑膜炎球菌的免疫蛋白质组。将来自对脑膜炎球菌C株(L91543)和B株MC58表现出血清杀菌活性的10位健康个体的血清,与可商购的合并人血清一起用作探针抗血清。对来自两个脑膜炎球菌菌株的每个血清样品和活细胞进行免疫沉淀。通过质谱鉴定免疫沉淀的蛋白质。对来自每种血清的免疫蛋白质组的分析表明,大多数血清都可以识别泛反应性抗原以及受试者特异性抗原。在两种脑膜炎球菌菌株中都发现了大多数抗原,但少数是菌株特异性的。先前许多免疫沉淀蛋白已被表征为表面抗原,包括粘附素和蛋白酶,其中一些已被识别为疫苗候选抗原,例如H.N.A.。 fHBP,NadA和NHBA。数据清楚地证明了健康个体中脑膜炎球菌抗体的存在,无脑膜炎球菌感染史,且免疫应答差异很大。脑膜炎球菌免疫反应蛋白的鉴定为理解每种抗原在与运输相关的自然免疫中的作用提供了基础,并可能有助于设计疫苗接种策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号